Enzyme replacement therapy in pediatric patients with Gaucher disease: What should we use as maintenance dosage? (original) (raw)

Individualization of long-term enzyme replacement therapy for Gaucher disease

Gregory Pastores

Genetics in Medicine, 2005

View PDFchevron_right

Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations

Neal Weinreb

The Journal of Pediatrics, 2004

View PDFchevron_right

Optimal therapy in Gaucher disease

Ozlem Goker-alpan

Therapeutics and Clinical Risk Management, 2010

View PDFchevron_right

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher’s disease: a systematic review

Christopher McCabe

View PDFchevron_right

Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy

S. Sukno

Journal of inherited metabolic disease, 1998

View PDFchevron_right

Effects of enzyme replacement therapy in thirteen Japanese paediatric patients with Gaucher disease

Owen Rennert

European Journal of Pediatrics, 2001

View PDFchevron_right

Outcome of enzyme replacement therapy in children with Gaucher disease: The Egyptian experience

eman monir

World Pumps, 2011

View PDFchevron_right

Enzyme replacement treatment in type 1 and type 3 Gaucher's disease

Bruno Bembi

The Lancet, 1994

View PDFchevron_right

Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease

Jaime Dalmau

Orphanet Journal of Rare Diseases, 2017

View PDFchevron_right

Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoring

Kieran McHugh

European Journal of Pediatrics, 2004

View PDFchevron_right

Long-term effectiveness of enzyme replacement therapy in adults with Gaucher disease: results from the NCS-LSD cohort study

Katrina Wyatt

Journal of Inherited Metabolic Disease, 2014

View PDFchevron_right

Gaucher disease: Enzyme therapy in the acute neuronopathic variant

Nelson Sanchez

American Journal of Medical Genetics, 1997

View PDFchevron_right

The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher’s disease

Edythe Wiggs

The Journal of Pediatrics, 2001

View PDFchevron_right

Revised recommendations for the management of Gaucher disease in children

Paige Kaplan, Lynne Steinbach, Amal El-beshlawy

European Journal of Pediatrics, 2013

View PDFchevron_right

Gaucher disease and its treatment options

Lunawati Bennett

The Annals of pharmacotherapy, 2013

View PDFchevron_right

Enzyme replacement therapy for Gaucher disease

Arthur Dawson

Blood, 1991

View PDFchevron_right

Type I Gaucher disease (GDI) in three siblings: enzyme replacement treatment (ERT) required

Nada Pop-jordanova

Prilozi / Makedonska akademija na naukite i umetnostite, Oddelenie za biološki i medicinski nauki = Contributions / Macedonian Academy of Sciences and Arts, Section of Biological and Medical Sciences

View PDFchevron_right

Clinical Consequences of Interrupting Enzyme Replacement Therapy in Children with Type 1 Gaucher Disease

Guillermo Drelichman

The Journal of Pediatrics, 2007

View PDFchevron_right

Enzyme-replacement therapy for Gaucher's disease

Bruno Bembi

The New England journal of medicine, 1991

View PDFchevron_right

The Iraqi Experience in the Treatment of Gaucher Disease in Children by Enzyme Replacement therapy

Mohammad Ibraheem

View PDFchevron_right

Enzyme replacement therapy for Gaucher's disease: the early Canadian experience

Joe Clarke

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1998

View PDFchevron_right

Study of enzyme replacement therapy for Gaucher Disease: comparative analysis of clinical and laboratory parameters at diagnosis and after two, five and ten years of treatment

Thiago Muniz

Revista Brasileira de Hematologia e Hemoterapia, 2014

View PDFchevron_right

Type I Gaucher Disease in Children with and Without Enzyme Therapy

Ari Zimran

Pediatric Hematology and Oncology, 2002

View PDFchevron_right

Brief Report-Extended Interval between Enzyme Therapy Infusions for Adult Patients with Gaucher's Disease Type 1

Pilar Giraldo

Journal of …, 2003

View PDFchevron_right